Tissue engineering for cutaneous wounds: An overview of current standards and possibilities

European Surgery - Acta Chirurgica Austriaca

Volumn 40, Issue 1, 2008, Pages 19-26

  Kamolz, Lars Peter ^a   Lumenta, D B ^a   Kitzinger, H B ^a   Frey, M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Dermal matrix; Dermal replacements; Epidermal replacements; Keratinocytes; Tissue engineering

Indexed keywords

ALLOTRANSPLANTATION; AUTOTRANSPLANTATION; CHRONIC WOUND; CLINICAL ARTICLE; DECUBITUS; DIABETES MELLITUS; HUMAN; PATHOLOGY; REVIEW; SKIN DEFECT; SKIN INJURY; SKIN TRANSPLANTATION; STANDARD; THERMAL INJURY; TISSUE ENGINEERING; TREATMENT OUTCOME; ULCER; VENOUS STASIS; WOUND CARE; WOUND CLOSURE; WOUND HEALING;

EID: 40649107836     PISSN: 16821769     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10353-008-0380-6     Document Type: Review

References (44)

1. Singer AJ, Clark RA (1999) Cutaneous wound healing. N Engl J Med 341: 738-746
2. Mustoe T (2004) Understanding chronic wounds: a unifying hypothesis on their pathogenesis and implications for therapy. Am J Surg 187: 65S-70S
3. Clark RAF, An J-Q, Greiling D, Khan AJ, Schwarzbauer J (2003) Fibroblast migration on fibronectin requires 3 distinct functional domains. J Invest Dermatol 121: 695-705
4. Ehrenreich M, Ruszczak Z (2006) Update on tissue-engineered biological dressings. Tissue Eng 12: 1-18
5. Redd MJ, Cooper L, Wood W, Stramer B, Martin P (2004) Wound healing and inflammation: embryos reveal the way to perfect repair. Philos Trans Roy Soc London B 359: 777-784
6. Engler AJ, Sen S, Sweeney HL, Discher DE (2006) Matrix elasticity directs stem cell lineage specification. Cell 126: 677-689
7. Vogel V, Sheetz M (2006) Local force and geometry sensing regulate cell functions. Nat Rev Mol Cell Biol 7: 265-275
8. Clark RAF, Gosh K, Tonnesen MG (2007) Tissue engineering for cutaneous wounds. J Invest Dermatol 127: 1018-1029
9. O'Conner NE, Mulliken JB, Banks-Schlegel S, Kehinde O, Green H (1981) Grafting of burns with cultured epithelium prepared from autologous epidermal cells. Lancet 1: 75-78
10. Rab M, Koller R, Ruzicka M, Burda G, Kamolz LP, Bierochs B, Meissl G, Frey M (2005) Should dermal scald burns in children be covered with autologous skin grafts or with allogeneic cultivated keratinocytes? - "The Viennese concept". Burns 31: 578-586
11. Kamolz LP, Kitzinger HB, Andel H, Frey M (2007) The surgical treatment of acute burns. Eur Surg 38: 417-423
12. Kamolz LP, Luegmair M, Wick N, Eisenbock B, Burjak S, Koller R, Meissl G, Frey M (2005) The Viennese culture method: cultured human epithelium obtained on a dermal matrix based on fibroblast containing fibrin glue gels. Burns 31: 25-29
13. Koller R, Bierochs B, Meissl G, Rab M, Frey M (2002) The use of allogeneic cultivated keratinocytes for the early coverage of deep dermal burns - indications, results and problems. Cell Tissue Bank 3: 11-14
14. Rheinwald JG, Green H (1975) Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 6: 331-344
15. Green H, Kehinde O, Thomas J (1979) Growth of cultured human epidermal cells into multiple epithelia suitable for grafting. Proc Natl Acad Sci USA 76: 5665-5668
16. Gallico GG III, O'Connor NE, Compton CC, Kehinde O, Green H (1984) Permanent coverage of large burn wounds with autologous cultured human epithelium. N Engl J Med 311: 448-451
17. Munster AM (1996) Cultured skin for massive burns. A prospesctive, controlled trial. Ann Surg 224: 372-377
18. Thivolet J, Faure M, Demidem A, Mauduit G (1986) Long term survival and immunological tolerance of human epidermal allografts produced in culture. Transplantation 42: 274-280
19. Leigh IM, Purkis PE, Navasaria HA, Phillips TJ (1987) Treatment of chronic venous ulcers with sheets of cultured allogeneic keratinocytes. Br J Dermatol 117: 591-597
20. Teepe RGC, Koebrugge EJ, Ponec M, Vermeer BJ (1990) Fresh versus cryopreserved cultured allografts for the treatment of chronic skin ulcers. Br J Dermatol 122: 81-89
21. Williamson JS, Snelling CF, Clugston P, Macdonald IB, Germann E (1995) Cultured epithelial autograft: five years of clinical experience with twenty-eight patients. J Trauma 39: 309-319
22. Campoccia D, Doherty P, Radice M, Brun P, Abatangelo G, Williams DF (1998) Semisynthetic resorbable materials from hyaluronan esterification. Biomaterials 19(23): 2101-2127
23. Rajab TK, Wallwiener C, Wallwiener M, Kraemer B (2007) Cost analysis of Jelonet (R) versus Suprathel (R) in the management of split-thickness skin graft donor sites. Burns Oct 3; PMID: 17919822 [Epub ahead of print]
24. Schwarze H, Kuntscher M, Uhlig C, Hierlemann H, Prantl L, Noack N, Hartmann B (2007) Suprathel(R), a new skin substitute, in the management of donor sites of split-thickness skin grafts: results of a clinical study. Burns 33: 850-854
25. Uhlig C, Rapp M, Hartmann B, Hierlemann H, Planck H, Dittel KK (2007) Suprathel - an innovative, resorbable skin substitute for the treatment of burn victims. Burns 33: 221-229
26. Cuono C, Langdon R, McGuire J (1986) Use of cultured epidermal autografts and dermal allografts as skin replacement after burn injury. Lancet 1: 1123-1124
27. Burke JF, Yannas IV, Quinby WC Jr, Bondoc CC, Jung WK (1981) Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury. Ann Surg 194: 413-428
28. Heimbach D, Luterman A, Burke J, Cram A, Herndon D, Hunt J, Jordan M, McManus W, Solem L, Warden G, et al (1988) Artificial dermis for major burns: a multicenter randomized clinical trial. Ann Surg 208: 313-320
29. Purdue GF (1997) Dermagraft-TC pivotal safety and efficacy study. J Burn Care Rehabil 18: S13-S14
30. Gentzkow GD, Iwasaki SD, Hershon KS, Mengel M, Prendergast JJ, Ricotta JJ, Steed DP, Lipkin S (1996) Use of dermagraft: a cultured human dermis to treat diabetic foot ulcers. Diabetes Care 19: 350-354
31. Marston WA, Hanft J, Norwood P, Pollak R (2003) The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care 26: 1701-1705
32. Mostow EN, Haraway GD, Dalsing M, Hodde JP, King D (2005) Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: a randomized clinical trial. J Vasc Surg 41: 837-843
33. Haslik W, Kamolz LP, Nathschlager G, Andel H, Meissl G, Frey M (2007) First experiences with the collagen-elastin matrix Matriderm as a dermal substitute in severe burn injuries of the hand. Burns 33: 364-368
34. Ryssel H, Gazyakan E, Germann G, Ohlbauer M (2007) The use of Matriderm (R) in early excision and simultaneous autologous skin grafting in burns - a pilot study. Burns Jul 16, PMID: 17644263 [Epub ahead of print]
35. Eaglstein WH, Alvarez OM, Auletta M, Leffel D, Rogers GS, Zitelli JA, Norris JE, Thomas I, Irondo M, Fewkes J, Hardin-Young J, Duff RG, Sabolinski ML (1999) Acute excisional wounds treated with a tissue engineered skin (Apligraf). Dermatol Surg 25: 195-201
36. Falanga V, Margolis D, Alvarez O, Auletta M, Maggiacomo F, Altman M, Jensen J, Sabolinski M, Hardin-Young J (1998) Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group [see comments]. Arch Dermatol 134: 293-300
37. Still J, Glat P, Silverstein P, Griswold J, Mozingo D (2003) The use of a collagen sponge/living cell composite material to treat donor sites in burn patients. Burns 29: 837-841
38. Balasubramani M, Kumar TR, Babu M (2001) Skin substitutes: a review. Burns 27: 534-544
39. Welch MP, Odland GF, Clark RAF (1990) Temporal relationships of F-actin bundle formation, collagen and fibronectin matrix assembly, and fibronectin receptor expression to wound contraction. J Cell Biol 110: 133-145
40. Mosesson MW (2005) Fibrinogen and fibrin structure and functions. J Thromb Haemost 3: 1894-1904
41. Richardson TP, Peters MC, Ennett AB, Mooney DJ (2001) Polymeric system for dual growth factor delivery. Nat Biotechnol 19: 1029-1034
42. McClain SA, Simon M, Jones E, Nandi A, Gailit JO, Tonnesen MG, Newman D, Clark RA (1996) Mesenchymal cell activation is the rate limiting step of granulation tissue induction. Am J Pathol 149: 1257-1270
43. Sahni A, Sahni SK, Simpson-Haidaris PJ, Francis CW (2004) Fibrinogen binding potentiates FGF-2 but not VEGF induced expression of u-PA, u-PAR, and PAI-1 in endothelial cells. J Thromb Haemost 2: 1629-1636
44. Klagsbrun M (1990) The affinity of fibroblast growth factors (FGFs) for heparin; FGF heparin sulfate interactions in cells and extracellular matrix. Curr Opin Cell Biol 2: 857-863